Literature DB >> 19231583

p38 MAPK regulates ischemia-reperfusion-induced recruitment of leukocytes in the colon.

Stefan Santén1, Andrada Mihaescu, Matthias W Laschke, Michael D Menger, Yousheng Wang, Bengt Jeppsson, Henrik Thorlacius.   

Abstract

BACKGROUND: Our objective was to examine the role of p38 mitogen-activated protein kinase (MAPK) in ischemia-reperfusion (I/R)-induced recruitment or leukocytes in the colon.
METHODS: C57/Bl6 mice were subjected to 30 minutes of ischemia by clamping the superior mesenteric artery followed by 2 hours of reperfusion. Animals were pretreated with the selective p38 MAPK inhibitors SB 239063 and SKF 86002 before induction of I/R. Leukocyte-endothelium interactions were quantified by use of intravital fluorescence microscopy. Additionally, the role of p38 MAPK in mast cell-generated tumor necrosis factor-alpha (TNF-alpha) as well as neutrophil adhesion and P-selectin expression were examined in vitro.
RESULTS: SB 239063 and SKF 86002 decreased both I/R-provoked leukocyte rolling and adhesion by > 75%. Inhibition of p38 MAPK decreased dose-dependently the mast cell generated TNF-alpha production as well as TNF-alpha-induced expression of P-selectin and neutrophil adhesion on endothelial cells.
CONCLUSION: We conclude that p38 MAPK regulates leukocyte rolling and adhesion in colonic I/R. Moreover, inhibition of p38 MAPK activity decreases formation of TNF-alpha and P-selectin-dependent leukocyte attachment to activated endothelial cells. Thus, our findings suggest that interference with the p38 MAPK signaling pathway could be an effective strategy to protect against I/R-induced inflammation in the colon.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231583     DOI: 10.1016/j.surg.2008.10.011

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

Review 1.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

2.  Ischemic post-conditioning to counteract intestinal ischemia/reperfusion injury.

Authors:  Yan-Fang Guan; Timothy A Pritts; Marshall H Montrose
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

Review 3.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

4.  Elevated postischemic tissue injury and leukocyte-endothelial adhesive interactions in mice with global deficiency in caveolin-2: role of PAI-1.

Authors:  Yajun Liu; Meifang Wang; Derek Wang; William P Fay; Ronald J Korthuis; Grzegorz Sowa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-08       Impact factor: 4.733

5.  Remifentanil Promotes PDIA3 Expression by Activating p38MAPK to Inhibit Intestinal Ischemia/Reperfusion-Induced Oxidative and Endoplasmic Reticulum Stress.

Authors:  Jiantong Shen; Yaqing Zhan; Qiulan He; Qiwen Deng; Kunhe Li; Shihong Wen; Wenqi Huang
Journal:  Front Cell Dev Biol       Date:  2022-01-26

6.  Pharmacological inhibition of p38 mitogen-activated protein kinases affects KC/CXCL1-induced intraluminal crawling, transendothelial migration, and chemotaxis of neutrophils in vivo.

Authors:  Najia Xu; Mokarram Hossain; Lixin Liu
Journal:  Mediators Inflamm       Date:  2013-03-04       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.